Motolimod is indicated for ovarian cancer patients whose disease has progressed on or recurred after platinum-based chemotherapy. The new Toll-like receptor 8 (TLR8) immunotherapy, motolimid is currently being
The active substance in Somatuline is lanreotide acetate, a somatostatin analogue that inhibits the secretion of several endocrine, exocrine and paracrine amines and peptides. Decision from the FDA
The commercialization of the product will be done in Hong Kong and Macao Special Administrative Regions and Taiwan. As part of the deal, Eddingpharm will oversee the clinical
Ryzodeg is a combination of insulin degludec and insulin aspart in the ratio of 70% and 30%, respectively. It is the first combination of a basal insulin with
In the US, Vimpat is already approved as adjunctive treatment for partial-onset seizures in patients belonging to this age group. The new indication means that adults aged 17
The trial evaluated clinical and demographic predictors of all-cause hospitalization in patients with VTE, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). During the 12-month extended
The trial evaluated 96 New York Heart Association (NYHA) Class II-III patients with heart failure and an ejection fraction of less than 35%. During the trial, all patients
The double blind, placebo controlled Phase IIb dose ranging trial was conducted in specialized cardiovascular centres across Denmark and the Netherlands. In the trial, a total of 364
Decitabine for injection is a generic version of Japanese pharmaceutical firm Eisai’s Dacogen. The drug is used to treat patients with myelodysplastic syndromes (MDS) including previously treated and
Scheduled to be initiated within weeks, the dose ranging efficacy trial in an experimental Ebola virus disease model in non-human primates represents a major step towards understanding the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.